IL6 and periodontal disorder: Therefore, treating periodontal disease not only reduces pro-inflammatory mediators such as IL-6, tumor necrosis factor-α (TNF-α), CRP, and reactive oxygen species (ROS), but also increases the levels of pro-resolving lipid mediators, which are crucial for maintaining homeostasis [5].